3TC

3TC Adverse Reactions

lamivudine

Manufacturer:

GlaxoSmithKline

Distributor:

Zuellig Pharma
Full Prescribing Info
Adverse Reactions
The following events have been reported during therapy for HIV disease with 3TC alone and in combination with other anti-retroviral agents. With many it is unclear whether they are related to the medicinal products or are as a result of the underlying disease process.
The following convention has been utilised for the classification of undesirable effects: very common (>1/10), common (>1/100, <1/10), uncommon (>1/1,000, <1/100), rare (>1/10,000, <1/1,000) very rare (<1/10,000).
Blood and lymphatic systems disorders: Uncommon: Neutropenia, anaemia, thrombocytopenia. Very rare: Pure red cell aplasia.
Metabolism and nutrition disorders: Common: Hyperlactataemia. Rare: Lactic acidosis (see Precautions).
Nervous system disorders: Common: Headache. Very rare: Paraesthesia. Peripheral neuropathy has been reported although a causal relationship to treatment is uncertain.
Gastrointestinal disorders: Common: Nausea, vomiting, upper abdominal pain, diarrhoea. Rare: Pancreatitis, although a causal relationship to treatment is uncertain. Rises in serum amylase.
Hepatobiliary disorders: Uncommon: Transient rises in liver enzymes (AST, ALT).
Skin and subcutaneous tissue disorders: Common: Rash, alopecia.
Musculoskeletal and connective tissue disorders: Common: Arthralgia, muscle disorders. Rare: Rhabdomyolysis.
General disorders and administration site conditions: Common: Fatigue, malaise, fever.
Paediatric population: The safety database to support lamivudine once daily dosing in paediatric patients comes from the ARROW Trial (COL105677) in which 669 HIV-1 infected paediatric subjects received abacavir and lamivudine either once or twice daily (see Pharmacology: Pharmacodynamics: Clinical Studies under Actions). No additional safety issues have been identified in paediatric subjects receiving either once or twice daily dosing compared to adults.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in